Novo Nordisk A/S Common Stock (NVO)

CapEx to Revenue

16.31%

Quarterly · Period ending:

NVO logo

NVO CapEx to Revenue

Latest reported16.31%
NVO Quarterly CapEx/Revenue (0.00% → 16.31%)
High-resolution chart · PNG

NVO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
16.3095%
12.434%
55.3889%
20.5599%
21.1757%
18.6792%
19.3247%
16.9946%
19.4505%
13.786%
24.9548%
18.0893%
12.9558%
8.9962%
12.8358%
9.2723%
6.2402%
4.235%
6.0366%
4.7386%
5.702%
4.4344%
40.155%
19.6786%
4.5558%
5.0863%
9.1557%
8.082%
9.2522%
10.3684%
13.3896%
10.4892%
9.337%
10.984%
11.5426%
7.5261%
5.9432%
6.0172%
9.3501%
9.46%
6.395%
4.193%
11.0022%
4.7962%
4.2389%
3.1627%
6.3575%
4.8631%
4.1102%
3.9375%
3.9405%
4.8852%
4.1674%
4.4838%
5.448%
5.2305%
4.5254%
3.1604%
7.1302%
4.21%
4.5997%
3.8743%
8.6331%
5.7752%
5.0734%
6.026%
9.0492%
6.3673%
4.1997%
4.3207%
6.3627%
4.1054%
4.4869%
2.5824%
6.8319%
5.8576%
5.7689%
4.6049%
10.3191%
8.761%
8.2008%
6.6713%
14.393%
12.4101%
8.8047%
9.9684%
15.7224%
11.6199%
9.4117%
5.9259%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.